 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Finch Therapeutics Group (NASDAQ:FNCH  Get Free Report) and Qiagen (NYSE:QGEN  Get Free Report) are both medical companies, but which is the superior stock? We will compare the two...

Analyzing Finch Therapeutics Group (NASDAQ:FNCH) & Qiagen (NYSE:QGEN)

Finch Therapeutics Group, Inc. (NASDAQ:FNCH  Free Report)  Stock analysts at HC Wainwright dropped their Q3 2023 earnings per share estimates for shares of Finch Therapeutics Group in a research note issued on Monday, August 21st. HC Wainwright analyst V. Bernardino now forecasts that ...

Q3 2023 Earnings Forecast for Finch Therapeutics Group, Inc. Issued By HC Wainwright (NASDAQ:FNCH)

Theres a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Nuvation Bio (NUVB Research Report), Finch Therape... Theres a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Nuvation Bio (NUVB Research Report), Finch ...

Analysts Are Bullish on These Healthcare Stocks: Nuvation Bio (NUVB), Finch Therapeutics Group (FNCH)

Finch Therapeutics Group, Inc. (NASDAQ:FNCH  Get Rating) was the recipient of a large increase in short interest in the month of May. As of May 31st, there was short interest totalling 106,900 shares, an increase of 73.5% from the May 15th total of 61,600 shares. Based on an average daily ...

Short Interest in Finch Therapeutics Group, Inc. (NASDAQ:FNCH) Increases By 73.5%

Thinking about buying stock in T Rowe Price, Ross Stores, Davita, Catalent, or Finch Therapeutics? Thinking about buying stock in T Rowe Price, Ross Stores, Davita, Catalent, or Finch Therapeutics? PR Newswire NEW YORK, June 13, 2023 NEW YORK, June 13, 2023 /PRNewswire/ -- InvestorsObserver issues...

Thinking about buying stock in T Rowe Price, Ross Stores, Davita, Catalent, or Finch Therapeutics?

BOSTON, June 09, 2023 (GLOBE NEWSWIRE) -- Finch Therapeutics Group, Inc. (Finch, Finch Therapeutics or the Company) (Nasdaq: FNCH), a microbiome technology company with a portfolio of intellectual property and microbiome assets, today announced it will effect a one-for-30 reverse stock split of its ...

Finch Announces Reverse Stock Split of Common Stock

Finch Therapeutics Group, Inc. (NASDAQ:FNCH  Get Rating)  Stock analysts at HC Wainwright increased their FY2024 earnings per share (EPS) estimates for shares of Finch Therapeutics Group in a research note issued to investors on Friday, May 12th. HC Wainwright analyst V. Bernardino now...

Finch Therapeutics Group, Inc. (NASDAQ:FNCH) Forecasted to Earn FY2024 Earnings of $0.99 Per Share

Finch Therapeutics Group, Inc. (NASDAQ:FNCH  Get Rating)  Analysts at HC Wainwright lifted their FY2024 earnings per share estimates for Finch Therapeutics Group in a research note issued on Friday, May 12th. HC Wainwright analyst V. Bernardino now expects that the company will post ...

Theres a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Finch Therapeutics Group (FNCH Research Report), K... Theres a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Finch Therapeutics Group (FNCH Research Report), ...

Analysts Are Bullish on Top Healthcare Stocks: Finch Therapeutics Group (FNCH), Kezar Life Sciences (KZR)

Finch Therapeutics forges a path forward, Insulet shakes up its C-suite, plus other biotech news in the Petri Dish...

The Petri Dish: Laronde CEO exits after 6 months; Enanta seeks Covid pill partner

Finch Therapeutics Group, Inc. engages in the development of microbiome drugs. Its platform includes Human-First Discovery that enables reverse translation from clinical data to engineer the composition of the microbiome based on disease-modifying mechanisms. The company was founded by Mark Smith, Andrew Noh, Tom Borody and Zain Kassam in 2014 and is headquartered in Boston, MA.

Watchers	655
52-Wk Low	$5.06
52-Wk High	$60.00

Market Cap	$8.52M
Volume (M)	1,722.00
52-Wk High	$60.00
52-Wk Low	$5.06

FNCH Finch Therapeutics Group Inc

About

Feed

News

Sentiment

Earnings

Fundamentals